Overcoming tumor cell multidrug resistance required a high enough intracellular concentration of paclitaxel to block the efflux action of P-glycoprotein (P-gp) while directly acting on the mitochondria to cut off the energy source of P-gp [171]. The gene discussed is PGP; the disease is neoplasm.